Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke
- PMID: 27339487
- DOI: 10.1016/j.jacc.2016.03.581
Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke
Abstract
Background: Oral anticoagulation (OAC), rather than aspirin, is recommended in patients with atrial fibrillation (AF) at moderate to high risk of stroke.
Objectives: This study sought to examine patient and practice-level factors associated with prescription of aspirin alone compared with OAC in AF patients at intermediate to high stroke risk in real-world cardiology practices.
Methods: The authors identified 2 cohorts of outpatients with AF and intermediate to high thromboembolic risk (CHADS2 score ≥2 and CHA2DS2-VASc ≥2) enrolled in the American College of Cardiology PINNACLE (Practice Innovation and Clinical Excellence) registry between 2008 and 2012. Using hierarchical modified Poisson regression models adjusted for patient and practice characteristics, the authors examined the prevalence and predictors of aspirin alone versus OAC prescription in AF patients at risk for stroke.
Results: Of 210,380 identified patients with CHADS2 score ≥2 on antithrombotic therapy, 80,371 (38.2%) were treated with aspirin alone, and 130,009 (61.8%) were treated with warfarin or non-vitamin K antagonist OACs. In the cohort of 294,642 patients with CHA2DS2-VASc ≥2, 118,398 (40.2%) were treated with aspirin alone, and 176,244 (59.8%) were treated with warfarin or non-vitamin K antagonist OACs. After multivariable adjustment, hypertension, dyslipidemia, coronary artery disease, prior myocardial infarction, unstable and stable angina, recent coronary artery bypass graft, and peripheral arterial disease were associated with prescription of aspirin only, whereas male sex, higher body mass index, prior stroke/transient ischemic attack, prior systemic embolism, and congestive heart failure were associated with more frequent prescription of OAC.
Conclusions: In a large, real-world cardiac outpatient population of AF patients with a moderate to high risk of stroke, more than 1 in 3 were treated with aspirin alone without OAC. Specific patient characteristics predicted prescription of aspirin therapy over OAC.
Keywords: CHA(2)DS(2)-VASc score; CHADS(2) score; aspirin; thromboembolism.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Aspirin in Atrial Fibrillation: The Clot Thickens.J Am Coll Cardiol. 2016 Jun 28;67(25):2924-6. doi: 10.1016/j.jacc.2016.03.582. J Am Coll Cardiol. 2016. PMID: 27339488 No abstract available.
-
Atrial fibrillation: Stroke prevention in atrial fibrillation: can we do better?Nat Rev Cardiol. 2016 Sep;13(9):511-2. doi: 10.1038/nrcardio.2016.117. Epub 2016 Jul 28. Nat Rev Cardiol. 2016. PMID: 27465652 No abstract available.
-
Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.J Am Coll Cardiol. 2016 Dec 6;68(22):2492. doi: 10.1016/j.jacc.2016.06.082. J Am Coll Cardiol. 2016. PMID: 27908358 No abstract available.
-
Reply: Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.J Am Coll Cardiol. 2016 Dec 6;68(22):2493. doi: 10.1016/j.jacc.2016.08.067. J Am Coll Cardiol. 2016. PMID: 27908359 No abstract available.
Similar articles
-
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.Circ Cardiovasc Qual Outcomes. 2017 May;10(5):e003476. doi: 10.1161/CIRCOUTCOMES.116.003476. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28506981
-
Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.JAMA Cardiol. 2016 Apr 1;1(1):55-62. doi: 10.1001/jamacardio.2015.0374. JAMA Cardiol. 2016. PMID: 27437655
-
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18. J Am Coll Cardiol. 2013. PMID: 24055744
-
Can we predict stroke in atrial fibrillation?Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):21-7. doi: 10.1002/clc.20969. Clin Cardiol. 2012. PMID: 22246948 Free PMC article. Review.
-
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.Adv Ther. 2017 Feb;34(2):357-377. doi: 10.1007/s12325-016-0458-7. Epub 2016 Dec 8. Adv Ther. 2017. PMID: 27933569 Free PMC article. Review.
Cited by
-
Stroke Risk Reduction in Atrial Fibrillation Through Pharmacist Prescribing: A Randomized Clinical Trial.JAMA Netw Open. 2024 Jul 1;7(7):e2421993. doi: 10.1001/jamanetworkopen.2024.21993. JAMA Netw Open. 2024. PMID: 39046741 Free PMC article. Clinical Trial.
-
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020.Am J Cardiovasc Drugs. 2024 May;24(3):433-444. doi: 10.1007/s40256-024-00638-4. Epub 2024 Apr 7. Am J Cardiovasc Drugs. 2024. PMID: 38583107
-
Racial and sex differences in optimizing anticoagulation therapy for patients with atrial fibrillation.Am Heart J Plus. 2022 Jul 2;18:100170. doi: 10.1016/j.ahjo.2022.100170. eCollection 2022 Jun. Am Heart J Plus. 2022. PMID: 38559416 Free PMC article.
-
Non‑persistence to Oral Anticoagulation Therapy in Elderly Patients with Non‑valvular Atrial Fibrillation.Patient Prefer Adherence. 2023 Dec 6;17:3185-3194. doi: 10.2147/PPA.S435592. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 38084322 Free PMC article.
-
Sociodemographic determinants of oral anticoagulant prescription in patients with atrial fibrillations: findings from the PINNACLE registry using machine learning.Heart Rhythm O2. 2022 Nov 24;4(3):158-168. doi: 10.1016/j.hroo.2022.11.004. eCollection 2023 Mar. Heart Rhythm O2. 2022. PMID: 36993910 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
